Disparities in risk perception and low harm reduction services awareness, access, and utilization among young people with newly reported hepatitis C infections in California, 2018
Open Access
- 21 July 2021
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 21 (1) , 1-10
Abstract
Background: Newly reported hepatitis C virus (HCV) infections in California increased 50% among people 15–29 years of age between 2014 and 2016. National estimates suggest this increase was due to the opioid epidemic and associated increases in injection drug use. However, most of California’s 61 local health jurisdictions (LHJs) do not routinely investigate newly reported HCV infections, so these individuals’ risk factors for infection are not well understood. We sought to describe the demographics, risk behaviors, and utilization of harm reduction services in California’s fastest-rising age group of people with newly reported hepatitis C infections to support targeted HCV prevention and treatment strategies. Methods: California Department of Public Health invited LHJs to participate in enhanced surveillance if they met criteria indicating heightened population risk for HCV infection among people ages 15–29. From June–December 2018, eight LHJs contacted newly reported HCV cases by phone using a structured questionnaire. Results: Among 472 total HCV cases who met the inclusion criteria, 114 (24%) completed an interview. Twenty-seven percent of respondents (n = 31) had ever been incarcerated, of whom 29% received a tattoo/piercing and 39% injected drugs while incarcerated. Among people who injected drugs (PWID)—36% (n = 41) of all respondents—68% shared injection equipment and many lacked access to harm reduction services: 37% knew of or ever used a needle exchange and 44% ever needed naloxone during an overdose but did not have it. Heroin was the most frequently reported injected drug (n = 30), followed by methamphetamine (n = 18). Pre-diagnosis HCV risk perception varied significantly by PWID status and race/ethnicity: 76% of PWID vs. 8% of non-PWID (p < 0.001), and 44% of non-Hispanic White respondents vs. 22% of people of color (POC) respondents (p = 0.011), reported thinking they were at risk for HCV before diagnosis. Eighty-nine percent of all respondents reported having health insurance, although only two had taken HCV antiviral medications. Conclusions: Among young people with HCV, we found limited pre-diagnosis HCV risk perception and access to harm reduction services, with racial/ethnic disparities. Interventions to increase harm reduction services awareness, access, and utilization among young PWID, especially young PWID of color, may be warranted.Keywords
This publication has 30 references indexed in Scilit:
- County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2016
- Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunitiesInternational Journal of Drug Policy, 2016
- Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug UsersJAMA Internal Medicine, 2014
- Estimating the Number of Persons Who Inject Drugs in the United States by Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus InfectionsPLOS ONE, 2014
- Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution TherapyClinical Infectious Diseases, 2013
- Race and Distance Effects on Regular Syringe Exchange Program Use and Injection Risks: A Geobehavioral AnalysisAmerican Journal of Public Health, 2010
- Intranasal Transmission of Hepatitis C Virus: Virological and Clinical EvidenceClinical Infectious Diseases, 2008
- The anatomy of risk: A quantitative investigation into injection drug users' taxonomy of risk attitudes and perceptions.Experimental and Clinical Psychopharmacology, 2007
- Effects of an Intensive Street-Level Police Intervention on Syringe Exchange Program Use in Philadelphia, PaAmerican Journal of Public Health, 2005
- Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention.2003